Cite
MLA Citation
Ricky K Hsu et al.. “1288. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND).” Open forum infectious diseases, vol. 9, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100174898681.0x00000c